Total Funding
58
53
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
102782
CytoSite Biopharma is a biotechnology start-up developing a new technology to predict and monitor response to Immuno-Oncology therapy.
- James Jenson: Founding CEO, DirectorPast Role: Dicerna Pharmaceuticals, Founding CEO, Director, SAB member
About the Company
CytoSite Biopharma is a biotechnology start-up developing a new technology to predict and monitor response to Immuno-Oncology therapy. The company develops a novel and proprietary small molecule PET imaging probe that will enable clinicians to predict early in the treatment cycle which patients will respond to I-O therapy.
It was founded by James
Jenson in 2016 and is based in Sudbury, Massachusetts.
